Migraine and its connections in neurology and psychiatry.
Roberts
Arthur C
AC
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D004878:Ergotamine / Q000009:adverse effects / Q000627:therapeutic use; D020773:Headache Disorders / Q000209:etiology; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009293:Opioid-Related Disorders / Q000209:etiology; D010166:Palliative Care; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000701:Analgesics, Opioid; D000927:Anticonvulsants; D000928:Antidepressive Agents; D017366:Serotonin Receptor Agonists; D004878:Ergotamine